WWW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Wolverine World Wide Inc. (WWW) is not a strong buy for a beginner, long-term investor at this time. The technical indicators suggest a bearish trend, and the stock appears fairly valued based on recent analyst ratings. While the company has shown moderate financial growth in Q3 2025, the lack of significant positive catalysts and the presence of negative sentiment from analysts and news events make it prudent to hold off on investing for now.
The technical indicators show a bearish trend. The MACD is negative and expanding, RSI is neutral at 36.352, and moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 18.025, with key support at 17.498 and resistance at 18.552.
Merrell's launch of the Agility Peak 6 trail running shoe and its involvement in the U.S. Skyrunner National Series for 2026 could expand its market presence in the outdoor and trail running segments. Additionally, the company reported YoY growth in revenue, net income, EPS, and gross margin in Q3 2025.
Eddie Bauer LLC's bankruptcy filing highlights tariff uncertainties and operational pressures, which could negatively impact Wolverine World Wide. Analysts have downgraded the stock due to weak direct-to-consumer revenue and concerns about future tariff pressures. The stock is also projected to decline in the short term, with an 80% chance of a -4.77% drop in the next week.
In Q3 2025, Wolverine World Wide reported a 6.84% YoY increase in revenue to $470.3M, a 7.02% YoY increase in net income to $24.4M, a 7.14% YoY increase in EPS to $0.3, and a 4.88% YoY increase in gross margin to 47.46%.
Recent analyst ratings are predominantly negative. Argus downgraded the stock to Hold from Buy, citing weak direct-to-consumer revenue and a fair valuation. BNP Paribas downgraded it to Neutral with a $19 price target. Piper Sandler downgraded it to Neutral with a $16 price target, citing challenges with key brands and tariff pressures. UBS maintained a Buy rating but lowered the price target to $26 from $28.
